Published in

American Chemical Society, Molecular Pharmaceutics, 10(11), p. 3291-3299, 2014

DOI: 10.1021/mp400641u

Links

Tools

Export citation

Search in Google Scholar

One Stone Kills Three Birds: Novel Boron-Containing Vesicles for Potential BNCT, Controlled Drug Release, and Diagnostic Imaging

Journal article published in 2014 by Gaojian Chen, Jingying Yang, Gang Lu ORCID, Pichu Liu, Qianjin Chen, Zuowei Xie, Chi Wu
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

A new conjugate polymer was prepared by an efficient thiol-ene coupling of one carborane with a linear PEG chain (Mn = 2,000 g/mol) and each carborane was further labeled with a fluorescence rhodamine dye. Such a novel polymer can associate in water to form narrowly distributed spherical vesicles that was characterized using a range of methods, including laser light scattering, confocal laser scanning microscopy and TEM. The vesicular structure is potentially multi-functional in biomedical applications; namely, serving as a boron neutron capture therapy (BNCT) agent, a hydrophilic drug carrier, and a diagnostic imaging fluorescent probe. As expected, either cleaving the thiol-ene linked PEO chain by esterase or destroying carborane by neutron irradiation results in a dismantlement of such a vesicle structure to release its encapsulated drugs. Its potential biomedical applications have been in vitro and in vivo evaluated. Our preliminary results reveal that these small vesicles can be quickly taken up by cells and have an enhanced stability in blood stream so that their targeting to specific cancer cells becomes feasible.